Simultaneous coexposure to inorganic mercury and cadmium: A study of the renal and hepatic disposition of mercury and cadmium

Journal of Toxicology and Environmental Health - Part A

Volumn 65, Issue 19, 2002, Pages 1471-1490

  Zalups, Rudolfs K ^a,b   Barfuss, Delon W ^a,b  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CADMIUM CHLORIDE; MERCURIC CHLORIDE; MERCURY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; FECES; KIDNEY CORTEX; KIDNEY METABOLISM; KIDNEY PROXIMAL TUBULE; LIVER METABOLISM; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; URINARY EXCRETION;

ANIMALS; CADMIUM; DRUG COMBINATIONS; DRUG INTERACTIONS; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; MALE; MERCURY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0037063901     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984100290071612     Document Type: Article

References (26)

1. Ballatori, N., and Clarkson, T. W. 1984. Dependence of biliary secretion of inorganic mercury on the biliary transport of glutathione. Biochem. Pharmacol. 33:1093-1098.
2. ++ in the renal proximal tubule. J. Am. Soc. Nephrol. 11:394-402.
3. Cannon, V. T., Zalups, R. K., and Barfuss, D. W. 2001. Amino acid transporters involved in the luminal transport of mercuric conjugates of cysteine in the rabbit proximal tubule. J. Pharmacol. Exp. Ther. 298:780-789.
4. Clarkson, T. W. 1993. Molecular and ionic mimicry of toxic metals. Annu. Rev. Pharmacol. Toxicol. 32:545-571.
5. Klaassen, C. D., and Liu, J. 1997. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab. Rev. 29:79-102.
6. Lash, L. H., and Jones, D. P. 1985. Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch. Biochem. Biophys. 240:583-592.
7. Madden, E. F., and Fowler, B. A. 2000. Mechanisms of nephrotoxicity from metal combinations: A review. Drug Chem. Toxicol. 23:1-12.
8. Prozialeck, W. C. 2000. Evidence the E-cadherin may be a target for cadmium toxicity in epithelial cells. Toxicol. Appl. Pharmacol. 164:231-249.
9. Rabenstein, D. L. 1989. Metal complexes of glutathione and their biological significance. In Glutathione: Chemical, biochemical and medical aspects, vol. 3, Coenzymes and cofactors, eds. D. Dolphin, O. Auramovibc, and R. Poulson, pp. 147-186. New York: Wiley.
10. Waalkes, M. P. 2000. Cadmium carcinogenesis in review. J. Inorg. Biochem. 79:241-244.
11. Zalups, R. K. 1991a. Method for studying the in vivo accumulation of inorganic mercury in segments of the nephron in the kidneys of rats treated with mercuric chloride. J. Pharmacol. Methods 26:89-104.
12. Zalups, R. K. 1991b. Autometallographic localization of inorganic mercury in the kidneys of rats: Effect of unilateral nephrectomy and compensatory renal growth. Exp. Mol. Pathol. 54:10-21.
13. Zalups, R. K. 1993. Early aspects of the intrarenal distribution of mercury after the intravenous administration of mercuric chloride. Toxicology 79:215-228.
14. Zalups, R. K. 1995. Organic anion transport and action of glutamyltranspeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury. Toxicol. Appl. Pharmacol. 132:289-298.
15. Zalups, R. K. 2000a. Molecular interactions with mercury in the kidney. Pharmacol. Rev. 52:113-143.
16. Zalups, R. K. 2000b. Evidence for basolateral uptake of cadmium in the kidneys of rats. Toxicol. Appl. Pharmacol. 164:15-23.
17. Zalups, R. K., and Barfuss, D. W. 1995a. Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat. Toxicology 103:23-35.
18. Zalups, R. K., and Barfuss, D. W. 1995b. Accumulation and handling of inorganic mercury in the kidney after co-administration with glutathione. J. Toxicol. Environ. Health 44:385-399.
19. Zalups, R. K., and Barfuss, D. W. 1995c. Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine. J. Toxicol. Environ. Health 44:401-413.
20. Zalups, R. K., and Barfuss, D. W. 1996. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury. Drug Metab. Dispos. 24:480-486.
21. Zalups, R. K., and Barfuss, D. W. 1998a. Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanism involved in the renal tubular uptake of inorganic mercury. J. Am. Soc. Nephrol. 9:551-561.
22. Zalups, R. K., and Barfuss, D. W. 1998b. Small aliphatic dicarboxylic acids inhibit renal uptake of administered mercury. Toxicol. Appl. Pharmacol. 148:183-193.
23. Zalups, R. K., and Lash, L. H. 1994. Advances in understanding the renal transport and toxicity of mercury. J. Toxicol. Environ. Health 42:1-44.
24. Zalups, R. K., and Minor, K. H. 1995. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury. J. Toxicol. Environ. Health 46:73-100.
25. Zalups, R. K., and Koropatnick, J. 2000. Temporal changes in metallothionein gene transcription in rat kidney and liver: Relationship to content of mercury and metallothionein protein. J. Pharmacol. Exp. Ther. 295:74-82.
26. Zalups, R. K., Parks, L., Cannon, V. T., and Barfuss, D. W. 1998. Mechanisms of action of 2,3-dimercaptopropane-1-sulfonate and the transport, disposition, and toxicity of inorganic mercury in isolated perfused segments of rabbit proximal tubules. Mol. Pharmacol. 54:353-363.